Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHSZX vs PHSTX
Shared holdings
14
PHSZX covered by PHSTX
37.01%
PHSTX covered by PHSZX
37.01%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHSZX (Feb. 27, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 16.46% | |
| (PIPA070) PGIM Core Government Money Market Fund | 7.57% | |
| MERCK & CO | 5.90% | |
| GILEAD SCIENCES INC | 4.29% | |
| UNITEDHEALTH GRP | 4.23% | |
| VERTEX PHARMACEUTICALS INC | 3.49% | |
| CVS HEALTH CORP | 3.21% | |
| LONZA GROUP -REG | 3.07% | |
| ARGENX SE SPONSORED ADR | 3.05% | |
| REGENERON PHARMACEUTICALS INC | 3.01% | |
| DANAHER CORP | 2.99% | |
| THERMO FISHER SCIENTIFIC INC | 2.74% | |
| ROIVANT SCIENCES LTD | 1.99% | |
| VAXCYTE INC | 1.92% | |
| TEVA PHARMACEUTICAL IND ADR | 1.90% | |
| BEONE MEDICINES LTD ADR | 1.87% | |
| PALVELLA THERAPEUTICS INC | 1.66% | |
| AGILENT TECHNOLOGIES INC | 1.66% | |
| SIONNA THERAPEUTICS INC | 1.60% | |
| SCHOLAR ROCK HOLDING CORP | 1.56% | |
| PRUDENTIAL INVESTMENT PORTFOLIOS 2 PRUDENTIAL INSTITUTIONA 0.00000000 | 1.55% | |
| EDWARDS LIFESCIENCES CORP | 1.53% | |
| XENON PHARMACEUTICALS INC | 1.52% | |
| INSMED INC | 1.34% | |
| KYMERA THERAPEUTICS INC | 1.33% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 1.27% | |
| APOGEE THERAPEUTICS INC | 1.13% | |
| ASTRAZENECA PLC | 1.11% | |
| Bayer Aktiengesellschaft | 1.02% | |
| CRINETICS PHARMACEUTICALS INC | 0.99% | |
| VIRIDIAN THERAPEUTICS INC | 0.91% | |
| DISC MEDICINE INC | 0.89% | |
| TANDEM DIABETES CARE INC | 0.84% | |
| APELLIS PHARMACEUTICALS INC | 0.84% | |
| PROTAGONIST THERAPEUTICS INC | 0.84% | |
| TARSUS PHARMACEUTICALS INC | 0.83% | |
| MINERALYS THERAPEUTICS INC | 0.79% | |
| CABALETTA BIO INC | 0.79% | |
| ALIGN TECHNOLOGY INC | 0.78% | |
| UCB SA | 0.74% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.71% | |
| REVOLUTION MEDICINES INC | 0.66% | |
| OLEMA PHARMACEUTICALS INC | 0.56% | |
| CELCUITY INC | 0.55% | |
| IMMUNOVANT INC | 0.52% | |
| TYRA BIOSCIENCES INC | 0.41% | |
| LB PHARMACEUTICALS INC | 0.37% | |
| Abivax SA SPONSORED ADS | 0.37% | |
| COMPASS Pathways PLC, ADR | 0.28% | |
| UNIQURE N.V. | 0.24% |
PHSTX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.32% | |
| JOHNSON&JOHNSON | 8.89% | |
| ABBVIE INC | 5.93% | |
| Novartis AG (Registered) | 5.52% | |
| MERCK & CO | 5.32% | |
| ASTRAZENECA PLC | 5.04% | |
| UNITEDHEALTH GRP | 4.92% | |
| INTUITIVE SURGICAL INC | 3.89% | |
| THERMO FISHER SCIENTIFIC INC | 3.70% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.90% | |
| BOSTON SCIENTIFIC CORP | 2.83% | |
| GILEAD SCIENCES INC | 2.68% | |
| MCKESSON CORP | 2.62% | |
| MEDTRONIC PLC | 2.47% | |
| Sanofi SA | 2.33% | |
| VERTEX PHARMACEUTICALS INC | 2.30% | |
| CARDINAL HEALTH INC | 2.27% | |
| BRISTOL-MYERS SQUIBB CO | 2.08% | |
| CVS HEALTH CORP | 1.84% | |
| Ascendis Pharma A/S | 1.67% | |
| EDWARDS LIFESCIENCES CORP | 1.62% | |
| HCA HEALTHCARE INC | 1.52% | |
| NOVO NORDISK-B | 1.45% | |
| Putnam Short Term Investment Fund, Class P | 1.32% | |
| ALNYLAM PHARMACEUTICALS INC | 1.31% | |
| CHUGAI PHARMA CO | 1.25% | |
| HOYA CORP | 1.24% | |
| REGENERON PHARMACEUTICALS INC | 1.23% | |
| UCB SA | 1.04% | |
| ARGENX SE | 1.01% | |
| ABBOTT LABS | 0.99% | |
| BECTON DICKINSON and CO | 0.98% | |
| GSK PLC | 0.95% | |
| VAXCYTE INC | 0.88% | |
| INSMED INC | 0.84% | |
| RHYTHM PHARMACEUTICALS INC | 0.63% | |
| US ULTRA BOND CBT Sep25 | 0.43% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.25% | |
| PRECIGEN INC | 0.22% | |
| Putnam Cash Collateral Pool LLC | 0.15% | |
| U.S. Treasury Bills | 0.12% | |
| U.S. Treasury Bills | 0.03% | |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0.00% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.